Form 4 for GH Guardant Health, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001576280-21-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-17 | 2021-08-13 | GH | Eltoukhy Helmy | Co-CEO, Dir | M - OptEx | $4.18 | +23.9K | 1.85M | +1% | +$100.0K |
| D | 2021-08-17 | 2021-08-13 | GH | Eltoukhy Helmy | Co-CEO, Dir | M - OptEx | $0.00 | -23.9K | 711.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-08-13 | M | A | 23,923 | $4.18 | 1,851,686 | D | — | — | (F1) Represents shares acquired by the Reporting Person through a cash exercise of a vested Stock Option Award. |
| 2 | Derivative | STOCK OPTION (RIGHT TO BUY) | 2021-08-13 | M | D | 23,923 | $0.00 | 711,612 | D | $4.18 · — to 2022-07-13 | 23,923 COMMON STOCK | (F2) The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. |